CaMKKβ-Dependent activation of AMP-activated protein kinase is critical to suppressive effects of hydrogen sulfide on neuroinflammation

Antioxidants and Redox Signaling

Volumn 21, Issue 12, 2014, Pages 1741-1758

  Zhou, Xiaomei ^a,b   Cao, Yongjun ^b   Ao, Guizhen ^a   Hu, Lifang ^a   Liu, Hui ^a   Wu, Jian ^a   Wang, Xiaoyu ^a   Jin, Mengmeng ^a   Zheng, Shuli ^a   Zhen, Xuechu ^a   Alkayed, Nabil J ^c   Jia, Jia ^a   Cheng, Jian ^a  

^a SOOCHOW UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN SULFIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; SMALL INTERFERING RNA; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE PRODUCT; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; PHENOTYPE; POLARIZATION; STIMULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; DEGENERATIVE DISEASE; INFLAMMATION; METABOLISM; MOUSE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE; CELLS, CULTURED; ENZYME ACTIVATION; HYDROGEN SULFIDE; INFLAMMATION; MICE; MICE, INBRED C57BL; MICROGLIA; NEURODEGENERATIVE DISEASES;

EID: 84906939797     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5587     Document Type: Article

References (50)

1. Abe K and Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 16: 1066-1071, 1996.
2. Abou-Mohamed G, Johnson JA, Jin L, El-Remessy AB, Do K, Kaesemeyer WH, Caldwell RB, and Caldwell RW. Roles of superoxide, peroxynitrite, and protein kinase C in the development of tolerance to nitroglycerin. J Pharmacol Exp Ther 308: 289-299, 2004.
3. Aguilar V, Alliouachene S, Sotiropoulos A, Sobering A, Athea Y, Djouadi F, Miraux S, Thiaudiere E, Foretz M, Viollet B, Diolez P, Bastin J, Benit P, Rustin P, Carling D, Sandri M, Ventura-Clapier R, and Pende M. S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating amp kinase. Cell Metab 5: 476-487, 2007.
4. Bai A, Ma AG, Yong M, Weiss CR, Ma Y, Guan Q, Bernstein CN, and Peng Z. Ampk agonist downregulates innate and adaptive immune responses in tnbs-induced murine acute and relapsing colitis. Biochem Pharmacol 80: 1708-1717, 2010.
5. Chi Y, Li K, Yan Q, Koizumi S, Shi L, Takahashi S, Zhu Y, Matsue H, Takeda M, Kitamura M, and Yao J. Nonsteroidal anti-inflammatory drug flufenamic acid is a potent activator of amp-activated protein kinase. J Pharmacol Exp Ther 339: 257-266, 2011.
6. Corton JM, Gillespie JG, Hawley SA, and Hardie DG. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating amp-activated protein kinase in intact cells? Eur J Biochem 229: 558-565, 1995.
7. Craft JM, Watterson DM, and Van Eldik LJ. Neuroinflammation: a potential therapeutic target. Expert Opin Ther Targets 9: 887-900, 2005.
8. David S and Kroner A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci 12: 388-399, 2011.
9. Giordanetto F and Karis D. Direct amp-activated protein kinase activators: a review of evidence from the patent literature. Expert Opin Ther Pat 22: 1467-1477, 2012.
10. Gong QH, Wang Q, Pan LL, Liu XH, Huang H, and Zhu YZ. Hydrogen sulfide attenuates lipopolysaccharide-induced cognitive impairment: a pro-inflammatory pathway in rats. Pharmacol Biochem Behav 96: 52-58, 2010.
11. Goransson O, McBride A, Hawley SA, Ross FA, Shpiro N, Foretz M, Viollet B, Hardie DG, and Sakamoto K. Mechanism of action of a-769662, a valuable tool for activation of amp-activated protein kinase. J Biol Chem 282: 32549-32560, 2007.
12. Green MF, Anderson KA, and Means AR. Characterization of the camkkbeta-ampk signaling complex. Cell Signal 23: 2005-2012, 2011.
13. Grin'kina NM, Karnabi EE, Damania D, Wadgaonkar S, Muslimov IA, and Wadgaonkar R. Sphingosine kinase 1 deficiency exacerbates lps-induced neuroinflammation. PLoS One 7: e36475, 2012.
14. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, Alessi DR, and Hardie DG. Complexes between the lkb1 tumor suppressor, strad alpha/beta and mo25 alpha/beta are upstream kinases in the amp-activated protein kinase cascade. J Biol 2: 28, 2003.
15. Hawley SA, Fullerton MD, Ross FA, Schertzer JD, Chevtzoff C, Walker KJ, Peggie MW, Zibrova D, Green KA, Mustard KJ, Kemp BE, Sakamoto K, Steinberg GR, and Hardie DG. The ancient drug salicylate directly activates amp-activated protein kinase. Science 336: 918-922, 2012.
16. Hu LF, Lu M, Hon Wong PT, and Bian JS. Hydrogen sulfide: neurophysiology and neuropathology. Antioxid Redox Signal 15: 405-419, 2011.
17. Hu LF, Wong PT, Moore PK, and Bian JS. Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. J Neurochem 100: 1121-1128, 2007.
18. Hu X, Li P, Guo Y, Wang H, Leak RK, Chen S, Gao Y, and Chen J. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 43: 3063-3070, 2012.
19. Jia J, Xiao Y, Wang W, Qing L, Xu Y, Song H, Zhen X, Ao G, Alkayed NJ, and Cheng J. Differential mechanisms underlying neuroprotection of hydrogen sulfide donors against oxidative stress. Neurochem Int 62: 1072-1078, 2013.
20. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, and Popovich PG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29: 13435-13444, 2009.
21. Kimura Y, Dargusch R, Schubert D, and Kimura H. Hydrogen sulfide protects ht22 neuronal cells from oxidative stress. Antioxid Redox Signal 8: 661-670, 2006.
22. Labuzek K, Liber S, Gabryel B, Adamczyk J, and Okopien B. Metformin increases phagocytosis and acidifies lysosomal/endosomal compartments in ampk-dependent manner in rat primary microglia. Naunyn Schmiedebergs Arch Pharmacol 381: 171-186, 2010.
23. Lee HJ, Mariappan MM, Feliers D, Cavaglieri RC, Sataranatarajan K, Abboud HE, Choudhury GG, and Kasinath BS. Hydrogen sulfide inhibits high glucose-induced matrix protein synthesis by activating amp-activated protein kinase in renal epithelial cells. J Biol Chem 287: 4451-4461, 2012.
24. Lee M, Sparatore A, Del Soldato P, McGeer E, and McGeer PL. Hydrogen sulfide-releasing nsaids attenuate neuroinflammation induced by microglial and astrocytic activation. Glia 58: 103-113, 2010.
25. Lee SK, Lee JO, Kim JH, Kim N, You GY, Moon JW, Sha J, Kim SJ, Lee YW, Kang HJ, Park SH, and Kim HS. Coenzyme q10 increases the fatty acid oxidation through ampk-mediated pparalpha induction in 3t3-l1 preadipocytes. Cell Signal 24: 2329-2336, 2012.
26. Liu YY, Sparatore A, Del Soldato P, and Bian JS. Acs84, a novel hydrogen sulfide-releasing compound, protects against amyloid beta-induced cell cytotoxicity. Neurochem Int 58: 591-598, 2011.
27. Lu DY, Tang CH, Chen YH, and Wei IH. Berberine suppresses neuroinflammatory responses through ampactivated protein kinase activation in bv-2 microglia. J Cell Biochem 110: 697-705, 2010.
28. Manna P and Jain SK. L-cysteine and hydrogen sulfide increase pip3 and ampk/ppargamma expression and decrease ros and vascular inflammation markers in high glucose treated human u937 monocytes. J Cell Biochem 114: 2334-2345, 2013.
29. Mantovani A, Biswas SK, Galdiero MR, Sica A, and Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 229: 176-185, 2013.
30. Martelli A, Testai L, Breschi MC, Blandizzi C, Virdis A, Taddei S, and Calderone V. Hydrogen sulphide: novel opportunity for drug discovery. Med Res Rev 32: 1093-1130, 2010.
31. Marutani E, Kosugi S, Tokuda K, Khatri A, Nguyen R, Atochin DN, Kida K, Van Leyen K, Arai K, and Ichinose F. A novel hydrogen sulfide-releasing n-methyl-d-aspartate receptor antagonist prevents ischemic neuronal death. J Biol Chem 287: 32124-32135, 2012.
32. Morikawa T, Kajimura M, Nakamura T, Hishiki T, Nakanishi T, Yukutake Y, Nagahata Y, Ishikawa M, Hattori K, Takenouchi T, Takahashi T, Ishii I, Matsubara K, Kabe Y, Uchiyama S, Nagata E, Gadalla MM, Snyder SH, and Suematsu M. Hypoxic regulation of the cerebral microcirculation is mediated by a carbon monoxide-sensitive hydrogen sulfide pathway. Proc Natl Acad Sci U S A 109: 1293-1298, 2012.
33. Nath N, Giri S, Prasad R, Salem ML, Singh AK, and Singh I. 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis. J Immunol 175: 566-574, 2005.
34. Nath N, Khan M, Paintlia MK, Singh I, Hoda MN, and Giri S. Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. J Immunol 182: 8005-8014, 2009.
35. O'Neill LA and Hardie DG. Metabolism of inflammation limited by ampk and pseudo-starvation. Nature 493: 346-355, 2013.
36. Owen MR, Doran E, and Halestrap AP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 348 Pt 3: 607-614, 2000.
37. Racioppi L and Means AR. Calcium/calmodulin-dependent protein kinase kinase 2: roles in signaling and pathophysiology. J Biol Chem 287: 31658-31665, 2012.
38. Racioppi L, Noeldner PK, Lin F, Arvai S, and Means AR. Calcium/calmodulin-dependent protein kinase kinase 2 regulates macrophage-mediated inflammatory responses. J Biol Chem 287: 11579-11591, 2012.
39. Russo GL, Russo M, and Ungaro P. Amp-activated protein kinase: a target for old drugs against diabetes and cancer. Biochem Pharmacol 86: 339-350, 2013.
40. Sag D, Carling D, Stout RD, and Suttles J. Adenosine 5¢- monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J Immunol 181: 8633-8641, 2008.
41. Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, Montminy M, and Cantley LC. The kinase lkb1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310: 1642-1646, 2005.
42. Shibuya N, Tanaka M, Yoshida M, Ogasawara Y, Togawa T, Ishii K, and Kimura H. 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal 11: 703-714, 2009b.
43. Szabó C. Hydrogen sulphide and its therapeutic potential. Nat. Rev. Drug Discov 6: 917-935, 2007.
44. Tiainen M, Ylikorkala A, and Mäkelä TP. Growth suppression by Lkb1 is mediated by a G1 cell cycle arrest. PNAS 96: 9248-9251, 1999.
45. Wang R. Physiological implications of hydrogen sulfide: a whiff exploration that blossomed. Physiol Rev 92: 791-896, 2012.
46. Wen YD, Wang H, Kho SH, Rinkiko S, Sheng X, Shen HM, and Zhu YZ. Hydrogen sulfide protects huvecs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress. PLoS One 8: e53147, 2013.
47. Whiteman M, Li L, Rose P, Tan CH, Parkinson DB, and Moore PK. The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages. Antioxid Redox Signal 12: 1147-1154, 2010.
48. Wiliñski B, Wiliñski J, Somogyi E, Piotrowska J, and Opoka W. Metformin raises hydrogen sulfide tissue concentrations in various mouse organs. Pharmacol Rep 65: 737-742, 2013.
49. Xue R, Hao DD, Sun JP, Li WW, Zhao MM, Li XH, Chen Y, Zhu JH, Ding YJ, Jun Liu, and Zhu YC. Hydrogen sulfide treatment promotes glucose uptake by increasing insulin receptor sensitivity and ameliorates kidney lesions in type 2 diabetes. Antioxid Redox Signal 19: 5-23, 2013.
50. Zhang Y and Ye J. Mitochondrial inhibitor as a new class of insulin sensitizer. Acta Pharm Sin B 2: 341-349, 2012.